Bryan Hurley, Ph.D., an associate investigator in the Mucosal Immunology and Biology Research Center at Mass General for Children and an associate professor of pediatrics at Harvard Medical School and Daniel Irimia, MD, Ph.D., ...
Nov 14, 2022
0
24
Reperfusion therapy, including intravenous recombinant tissue plasminogen activator (rtPA) and/or endovascular thrombectomy, is the most effective treatment for ischemic stroke. However, there is uncertainty regarding the ...
Nov 1, 2022
0
13
A large stroke trial has shown that intensive blood pressure lowering after clot removal worsens recovery. The results of the trial, stopped early due to the significance of the findings, were presented in a late-breaking ...
Oct 28, 2022
0
100
Expression of a pro-lymphangiogenic growth factor after heart injury activates the lymphatic system, spurring leukocytes to help clear away dying cells, according to a Northwestern Medicine study published in the Journal ...
Apr 6, 2022
0
15
Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology's 71st Annual Scientific Session. This was the ...
Apr 4, 2022
0
9
A University of South Florida Health (USF Health) preclinical study offers molecular insight into how activated protein C (APC) may improve aging patients' tolerance to reperfusion injury—a potentially adverse effect of ...
Jan 31, 2022
0
7
Researchers from the University of Notre Dame and the University of Florida have developed a sensor that could diagnose a heart attack in less than 30 minutes, according to a study published in Lab on a Chip.
Oct 1, 2021
0
6
Sirtuins are a family of anti-aging proteins that help regulate cellular lifespan, metabolism, and resistance to stress. The potential protective effect of these sirtuin enzymes in age-related diseases, including cardiovascular ...
Aug 24, 2021
0
7
Extracellular vesicles (EVs)—nanometer sized messengers that travel between cells to deliver cues and cargo—are promising tools for the next generation of therapies for everything from autoimmune and neurodegenerative ...
Oct 15, 2020
0
51
Researchers at the University of Illinois at Chicago have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet medications currently available.
Jul 16, 2020
0
47
